News und Analysen
Tvardi Posts Q2 Net Income Turnaround
Tvardi Therapeutics (NASDAQ:TVRD), a clinical-stage biopharmaceutical company focused on developing new therapies for serious diseases, released its second quarter fiscal 2025 results on August 14
BioCardia Narrows Loss in Fiscal Q2
BioCardia (NASDAQ:BCDA), a clinical-stage cell therapy company focused on treatments for heart disease, released its financial results for the second quarter of 2025 on August 11, 2025. The company
Helix Energy Q2 Revenue Falls 17%
Helix Energy Solutions Group (NYSE:HLX), a diversified offshore energy services provider, reported weaker-than-expected Q2 2025 results, released on July 23, 2025. The headline was a disappointing
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200), its dual inhibitor of B cell-activating
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will host a webcast and conference call on June 30, 2025, at 8:30 a.m. ET to discuss AUR200 Phase 1 study results. The link to
New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced that a post-hoc analysis of the 52-week, Phase 3 AURORA 1 study showed that lupus nephritis (LN) patients who
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three months ended March 31, 2025.
First Quarter 2025 Financial Results
-
Total Revenue: For the three
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release first quarter 2025 financial and operational results before markets open on May 12, 2025.
Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Glass, Lewis & Co. LLC (“Glass Lewis”) has recommended that Aurinia
ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder Services (“ISS”) has recommended that
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and twelve months ended December 31, 2024 and provided an update on recent corporate progress.
Fourth
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release 2024 fourth quarter and full year financial and operational results before markets open on
EnWave unterzeichnet Royalty-pflichtige kommerzielle Lizenzvereinbarung mit Shinyway International Limited aus Neuseeland
Vancouver, B.C., 12. November 2025 / IRW-Press / EnWave Corporation (TSX-V:ENW | FWB:E4U) („EnWave“ oder das „Unternehmen“) gab heute bekannt, dass es eine Royalty-pflichtige kommerzielle
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave unterzeichnet Lizenzvereinbarung mit US-amerikanischem Snackhersteller und verkauft 10-kW-Radiant-Energy-Vacuum-Anlage
Vancouver, BC, 10. November 2025 / IRW-Press / EnWave Corporation (TSX-V:ENW | FWB:E4U) („EnWave“ oder das „Unternehmen“) gab heute bekannt, dass es eine Royalty-pflichtige gewerbliche
EnWave unterzeichnet mit der brasilianischen Firma Solve Solutions Ltda. eine Royalty-pflichtige gewerbliche Lizenzvereinbarung und verkauft 10-kW-REV-Anlage
Vancouver, British Columbia, 29. September 2025 / IRW-Press / EnWave Corporation (TSX-V: ENW | FWB: E4U) („EnWave“ oder das „Unternehmen“) hat heute bekannt gegeben, dass mit dem
EnWave Signs Royalty-Bearing Commercial License with Solve Solutions Ltda of Brazil and Sells 10kW REV Machinery
Vancouver, B.C., September 29, 2025, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a royalty-bearing, commercial license agreement
EnWave verkauft Radiant Energy Vacuum-Maschine mit 120 kW Leistung an BranchOut Food und gewährt erweiterte globale Rechte für Drachenfruchtprodukte
Vancouver, B.C., 18. September 2025 / IRW-Press / EnWave Corporation (TSX-V:ENW | FWB:E4U) („EnWave“ oder das „Unternehmen“) gab heute bekannt, dass das Unternehmen eine
EnWave Sells 120kW Radiant Energy Vacuum Machine to BranchOut Food, Grants Expanded Global Rights for Dragon Fruit
Vancouver, B.C., September 18th, 2025, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an Equipment Purchase Agreement (the “EPA”)
EnWave meldet konsolidiertes Zwischenergebnis für das dritte Quartal 2025
Vancouver, B.C., 22. August 2025 / IRW-Press / EnWave Corporation (TSX-V:ENW | FWB:E4U) („EnWave“ oder das „Unternehmen“) veröffentlichte heute den konsolidierten Konzernzwischenabschluss des
EnWave Reports 2025 Third Quarter Consolidated Interim Financial Results
Vancouver, B.C., August 22nd, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the third
EnWave Corporation Announces Closing of Fully Subscribed $3 Million LIFE Offering
Not for distribution to United States newswire services or for dissemination in the United States
Vancouver, B.C., August 21st, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or
EnWave Corporation gibt Abschluss des vollständig gezeichneten LIFE-Emissionsangebots im Wert von 3 Millionen $ bekannt
Nicht zur Weitergabe an US-Nachrichtendienste oder Verbreitung in den Vereinigten Staaten bestimmt
Vancouver, B.C., 21. August 2025/ IRW-Press / EnWave Corporation (TSX-V:ENW | FWB:E4U) („E
EnWave Sells Two Additional 10kW Radiant Energy Vacuum Machines to Dairy Concepts Irl for Expanded Dairy Snack Production in Europe
Vancouver, B.C., July 30th, 2025 -EnWave Corporation (TSX-V:ENW / FSE:E4U) (“EnWave”, or the "Company") announced today that it has sold two additional 10kW Radiant Energy Vacuum (“REV™”)